摘要
目的:评价在高血压脑出血患者的临床治疗工作中,应用持续有创颅内压监测技术对其疗效及预后产生的积极影响。方法:将2020年1月~2022年1月本院68例高血压脑出血患者的临床资料以回顾性方式抽取,依据“是否接受持续有创颅内压监测”进行分组处理(确保每组34例病例),对照组未进行持续有创颅内压监测,观察组开展持续有创颅内压监测。结果:(1)经与对照组32.35%的并发症数据对比,观察组患者并发症发生率较低(P<0.05);(2)经与对照组患者临床指标数据对比,观察组患者甘露醇使用时间较短且剂量偏少(P<0.05);(3)治疗后经与对照组患者神经功能、预后情况指标相比,观察组患者神经功能、预后情况良好,且QLQ-30生活质量量表各指标数值明显更高(P<0.05)。结论:持续有创颅内压监测在高血压脑出血患者的临床治疗中具有较为显著的应用价值。
Objective:To evaluate the positive effect of continuous invasive intracranial pressure monitoring technology on the with hypertensive intracerebral hemorrhage.Methods:From January 2020 to January 2022,the clinical data of 68 patients with hypertensive intracerebral hemorrhage in our hospital were retrospectively extracted and grouped according to“whether to accept continuous pressure monitoring”(to ensure that 34 cases in each group).The control group invasive intracranial pressure monitoring,while the observation.Results:①Compared with 32.35%of the observed data of complications in the control group,the incidence of complications in the observation group was lower(P<0.05).②Compared with the observation data of clinical indicators the control group,the mannitol use time of patients in the observation group was shorter and the dose was less(P<0.05).③After treatment,the neurological functions of the patients in the observation group were,and the values of each index in the QLQ-30 quality of life scale were significantly higher(P<0.05).Conclusion:Continuous invasive intracranial pressure monitoring has significant treatment of hypertensive patients.
作者
左文博
ZUO Wen-bo(Department of Neurosurgery,Beijing Dawang Road Emergency Rescue Hospital,Beijing 100000)
出处
《中国医疗器械信息》
2024年第2期85-87,共3页
China Medical Device Information
关键词
高血压脑出血
持续有创颅内压监测
并发症
甘露醇
预后情况
hypertensive intracerebral hemorrhage
continuous invasive intracranial pressure monitoring
complication
mannitol
prognosis